US Patent Issued to CAAMTECH on Sept. 9 for "Crystalline 5-methoxy-N,N-diallyltryptamine compounds" (Washington Inventor)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,129, issued on Sept. 9, was assigned to CAAMTECH INC. (Issaquah, Wash.).

"Crystalline 5-methoxy-N,N-diallyltryptamine compounds" was invented by Andrew R. Chadeayne (Issaquah, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to 5-methoxy-N,N-diallyltryptamine ("5-MeO-DALT"), bis-(5-meth-oxy-N,N-di-allyl-tryptammonium) fumarate ("5-MeO-DALT fumarate"), and crystalline bis-(5-meth-oxy-N,N-di-allyl-tryptammonium) fumarate ("5-MeO-DALT fumarate"), compositions containing them, and the methods of treatment using them."

The patent was filed on July 11, 2023, under Application No. 18/350,103.

*For further information, includin...